Trials / Completed
CompletedNCT05994703
Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Rose Research Center, LLC · Industry
- Sex
- All
- Age
- 22 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the effects of a reward devaluation strategy, which has been researched in the past, combined/augmented with the medication d-cycloserine in assisting smokers to switch from combustible cigarette (CC) to Juul.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | d-cycloserine | d-cycloserine (DCS) 100 mg taken orally, once a day for six weeks. |
| OTHER | Juul e-cigarette | Juul use as often as the participant likes for 12 weeks. |
Timeline
- Start date
- 2023-10-20
- Primary completion
- 2025-10-13
- Completion
- 2026-01-12
- First posted
- 2023-08-16
- Last updated
- 2026-01-20
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05994703. Inclusion in this directory is not an endorsement.